MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

499505

Report Date :

26.03.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

EVEREST MEDICAL RESOURCES (M) SDN. BHD.

 

 

Formerly Known As :

EVEREST MEDICAL SDN BHD (06/05/2014)


CURA MEDICAL (M) SDN. BHD. (04/09/2007)

 

 

Registered Office :

2-9, Jalan Pm 14, Plaza Mahkota, 75000 Melaka, Melaka

 

 

Country :

Malaysia

 

 

Financials (as on) :

30.06.2016

 

 

Date of Incorporation :

11.04.2007

 

 

Com. Reg. No.:

769154-U

 

 

Legal Form :

Private Limited (Limited By Share)

 

 

Line of Business :

The subject is principally engaged in the trading of medical equipment.

 

 

No. of Employees :

Not Available

 

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

C

 

Credit Rating

 

Explanation

Rating Comments

C

Medium High Risk

Business dealings permissible preferably on secured basis

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.09.2017)

Current Rating

(31.12.2017)

Malaysia

A2

A2

 

Risk Category

 

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 


 

MALAYSIA - ECONOMIC OVERVIEW

 

Malaysia, an upper middle-income country, has transformed itself since the 1970s from a producer of raw materials into a multi-sector economy. Under current Prime Minister NAJIB, Malaysia is attempting to achieve high-income status by 2020 and to move further up the value-added production chain by attracting investments in high technology, knowledge-based industries and services. NAJIB's Economic Transformation Program is a series of projects and policy measures intended to accelerate the country's economic growth. The government has also taken steps to liberalize some services sub-sectors. Malaysia is vulnerable to a fall in world commodity prices or a general slowdown in global economic activity.

 

The NAJIB administration is continuing efforts to boost domestic demand and reduce the economy's dependence on exports. Domestic demand continues to anchor economic growth, supported mainly by private consumption, which accounts for 53% of GDP. Nevertheless, exports - particularly of electronics, oil and gas, and palm oil - remain a significant driver of the economy. In 2015, gross exports of goods and services were equivalent to 73% of GDP. The oil and gas sector supplied about 22% of government revenue in 2015, down significantly from prior years amid a decline in commodity prices and diversification of government revenues. Malaysia has embarked on a fiscal reform program aimed at achieving a balanced budget by 2020, including rationalization of subsidies and the 2015 introduction of a 6% value added tax. Sustained low commodity prices throughout the period not only strained government finances, but also shrunk Malaysia’s current account surplus and weighed heavily on the Malaysian ringgit, which was among the region’s worst performing currencies during 2013-17. The ringgit hit new lows following the US presidential election amid a broader selloff of emerging market assets.

 

Bank Negara Malaysia (the central bank) maintains adequate foreign exchange reserves; a well-developed regulatory regime has limited Malaysia's exposure to riskier financial instruments, although it remains vulnerable to volatile global capital flows. In order to increase Malaysia’s competitiveness, Prime Minister NAJIB raised possible revisions to the special economic and social preferences accorded to ethnic Malays under the New Economic Policy of 1970, but retreated in 2013 after he encountered significant opposition from Malay nationalists and other vested interests. In September 2013 NAJIB launched the new Bumiputra Economic Empowerment Program, policies that favor and advance the economic condition of ethnic Malays.

 

Malaysia signed the 12-nation Trans-Pacific Partnership (TPP) free trade agreement in February 2016, although the future of the TPP remains unclear following the US withdrawal from the agreement. Along with nine other ASEAN members, Malaysia established the ASEAN Economic Community in 2015, which aims to advance regional economic integration.

 

Source : CIA

 

 


 

 

EXECUTIVE SUMMARY

 

REGISTRATION NO.

:

769154-U

GST NO.

:

000442773504

COMPANY NAME

:

EVEREST MEDICAL RESOURCES (M) SDN. BHD.

FORMER NAME

:

EVEREST MEDICAL SDN BHD (06/05/2014)
CURA MEDICAL (M) SDN. BHD. (04/09/2007)

INCORPORATION DATE

:

11/04/2007

COMPANY STATUS

:

EXIST

LEGAL FORM

:

PRIVATE LIMITED (LIMITED BY SHARE)

LISTED STATUS

:

NO

REGISTERED ADDRESS

:

2-9, JALAN PM 14, PLAZA MAHKOTA, 75000 MELAKA, MELAKA, MALAYSIA.

BUSINESS ADDRESS

:

NO. 155, JALAN TU 3, TAMAN TASEK UTAMA,, 75450 AIR KEROH, MELAKA, MALAYSIA.

TEL.NO.

:

06-2533048

FAX.NO.

:

N/A

EMAIL

:

MANI@EVERESTMEDICAL.MY

CONTACT PERSON

:

THANGAMANI A/P RAMAN ( DIRECTOR )

INDUSTRY CODE

:

46421

PRINCIPAL ACTIVITY

:

TRADING OF MEDICAL EQUIPMENT

AUTHORISED CAPITAL

:

MYR 500,000.00 DIVIDED INTO 
ORDINARY SHARE 500,000.00 OF MYR 1.00 EACH.

ISSUED AND PAID UP CAPITAL

:

MYR 500,000.00 DIVIDED INTO 
ORDINARY SHARES 150,002 CASH AND 349,998 OTHERWISE OF MYR 1.00 EACH.

SALES

:

MYR 187,641 [2016]

NET WORTH

:

MYR 87,653 [2016]

STAFF STRENGTH

:

N/A

BANKER (S)

:

MALAYAN BANKING BHD

LITIGATION

:

CLEAR

DEFAULTER CHECK

:

CLEAR

FINANCIAL CONDITION

:

POOR

PAYMENT

:

SLOW

MANAGEMENT CAPABILITY

:

AVERAGE

COMMERCIAL RISK

:

HIGH

CURRENCY EXPOSURE

:

MODERATE

GENERAL REPUTATION

:

SATISFACTORY

INDUSTRY OUTLOOK

:

MARGINAL GROWTH

 

 

HISTORY / BACKGROUND

 

The Subject is a private limited company and is allowed to have a minimum of one and a maximum of forty-nine shareholders. As a private limited company, the Subject shall have a minimum one director. A private limited company is a separate legal entity from its shareholders. As a separate legal entity, the Subject is capable of owning assets, entering into contracts, sue or be sued by other companies. The liabilities of the shareholders are to the extent of the equity they have taken up and the creditors cannot claim on shareholders' personal assets even if the Subject is insolvent. The Subject is governed by the Companies Act, 1965 and the company must file its annual returns, together with its financial statements with the Registrar of Companies.

The Subject is principally engaged in the (as a / as an) trading of medical equipment.

The Subject is not listed on Bursa Malaysia (Malaysia Stock Exchange).

 

Former Address(es)

Address

As At Date

NO:656, 2ND FLOOR, 4TH MILE JALAN IPOH, 51200, WILAYAH PERSEKUTUAN, MALAYSIA

15/02/2013

NO.5, JALAN MH 1, TAMAN MUZAFFAR HEIGHTS, 75450, MELAKA, MALAYSIA

22/01/2015

NO. 3B, LEVEL 3, WISMA TAN CHENG TIONG, 75100, MELAKA, MALAYSIA

N/A

 

Share Capital History

Date

Authorised Shared Capital

Issue & Paid Up Capital

20/06/2014

MYR 500,000.00

MYR 500,000.00

15/02/2013

MYR 500,000.00

MYR 350,000.00

 

The major shareholder(s) of the Subject are shown as follows :


Current Shareholder(s) :

Name

Address

IC/PP/Loc No

Shareholding

(%)

PALANIAPPAN MUTHIAH +

19-01, AMBAI TOWER, GOLDEN COAST CONDOMINIUM, 75200 MELAKA, MELAKA, MALAYSIA.

E4787125C

371,000.00

74.20

SARASWATHI MUTHIAH +

19-01, AMBAI TOWER, GOLDEN COAST CONDOMINIUM, 75200 MELAKA, MELAKA, MALAYSIA.

E6126683D

79,000.00

15.80

UNNA MUTHIAH +

19-01, AMBAI TOWER, GOLDEN COAST CONDOMINIUM, KLEBANG BESAR, 75200 MELAKA, MELAKA, MALAYSIA.

N7676967

50,000.00

10.00

---------------

------

500,000.00

100.00

============

=====

+ Also Director


Former Shareholder(s) :

Name

Country

IC/PP/Loc No

Shareholding

Last Updated

CHANASEKAR SINTHALAPADI VIJAYAN

MALAYSIA

Z1690454

20,000.00

N/A

CHANDRASEKAR SINTHALAPADI VIJAYAN

MALAYSIA

Z3290004

20,000.00

N/A

USHA A/P K.S. VISWANATHAN

MALAYSIA

570413-08-5968

100,000.00

N/A



DIRECTORS

 

DIRECTOR 1

 

Name Of Subject

:

MS. THANGAMANI A/P RAMAN

Address

:

10, JALAN TU 22, TAMAN TASEK UTAMA, 75450 AIR KEROH, MELAKA, MALAYSIA.

IC / PP No

:

A1296693

New IC No

:

690919-04-5302

Date of Birth

:

19/09/1969

Nationality

:

MALAYSIAN

Date of Appointment

:

15/03/2013



INTEREST CHECK

Interest in companies

:

see below

Interest in business

:

none in our databank

Former interest

:

none in our databank

INTEREST IN COMPANY

No

Local No

Company

Designation

App Date

Shareholding

Profit/(loss) After Tax

Financial Year

Status

As At

No.

%

1

769154U

EVEREST MEDICAL RESOURCES (M) SDN. BHD.

Director

15/03/2013

0.00

-

MYR(101,566.00)

2016

-

23/02/2018

2

605391A

WISDOM ENGINEERING SDN. BHD.

Director

13/06/2004

10.00

10.00

-

-

Disolved by Registrar

23/02/2018

 

DIRECTOR 2

 

Name Of Subject

:

UNNA MUTHIAH

Address

:

19-01, AMBAI TOWER, GOLDEN COAST CONDOMINIUM, KLEBANG BESAR, 75200 MELAKA, MELAKA, MALAYSIA.

IC / PP No

:

N7676967

Date of Appointment

:

13/05/2013



INTEREST CHECK

Interest in companies

:

see below

Interest in business

:

none in our databank

Former interest

:

none in our databank

INTEREST IN COMPANY

No

Local No

Company

Designation

App Date

Shareholding

Profit/(loss) After Tax

Financial Year

Status

As At

No.

%

1

769154U

EVEREST MEDICAL RESOURCES (M) SDN. BHD.

Director

13/05/2013

50,000.00

10.00

MYR(101,566.00)

2016

-

23/02/2018

 

DIRECTOR 3

 

Name Of Subject

:

SARASWATHI MUTHIAH

Address

:

19-01, AMBAI TOWER, GOLDEN COAST CONDOMINIUM, 75200 MELAKA, MELAKA, MALAYSIA.

IC / PP No

:

E6126683D

Date of Birth

:

26/05/1963

Date of Appointment

:

12/03/2013



INTEREST CHECK

Interest in companies

:

see below

Interest in business

:

none in our databank

Former interest

:

none in our databank

INTEREST IN COMPANY

No

Local No

Company

Designation

App Date

Shareholding

Profit/(loss) After Tax

Financial Year

Status

As At

No.

%

1

769154U

EVEREST MEDICAL RESOURCES (M) SDN. BHD.

Director

12/03/2013

79,000.00

15.80

MYR(101,566.00)

2016

-

23/02/2018

 

DIRECTOR 4

 

Name Of Subject

:

PALANIAPPAN MUTHIAH

Address

:

19-01, AMBAI TOWER, GOLDEN COAST CONDOMINIUM, 75200 MELAKA, MELAKA, MALAYSIA.

IC / PP No

:

E4787125C

Date of Birth

:

19/12/1962

Date of Appointment

:

11/04/2007



INTEREST CHECK

Interest in companies

:

see below

Interest in business

:

none in our databank

Former interest

:

none in our databank

INTEREST IN COMPANY

No

Local No

Company

Designation

App Date

Shareholding

Profit/(loss) After Tax

Financial Year

Status

As At

No.

%

1

769154U

EVEREST MEDICAL RESOURCES (M) SDN. BHD.

Director

11/04/2007

371,000.00

74.20

MYR(101,566.00)

2016

-

23/02/2018



FORMER DIRECTOR(S)

 

Name

Address

IC/PP No

Appointed Date

Withdrawn Date

USHA A/P K.S. VISWANATHAN

NO. 7, TINGKAT GROVE, TAMAN IPOH GROVE, IPOH, PERAK, MALAYSIA

570413-08-5968

11/04/2007

12/03/2013

 

Note : The above information was generated from our database.



MANAGEMENT

 

 

1)

Name of Subject

:

THANGAMANI A/P RAMAN

Position

:

DIRECTOR

 

2)

Name of Subject

:

UNNA MUTHIAH

Position

:

MANAGING DIRECTOR

 

AUDITOR

 

Auditor

:

AA ASSOCIATES

Auditor' Address

:

NO. 6, JALAN MELAKA RAYA 35, TAMAN MELAKA RAYA, MALAYSIA.

 

COMPANY SECRETARIES

 

1)

Company Secretary

:

MS. TAHIRAH BINTI OSMAN

New IC No

:

811017-71-5096

Address

:

NO. 26, JALAN BKI 8, TAMAN BUKIT KATIL INDAH, 75450 AIR KEROH, MELAKA, MALAYSIA.

 

2)

Company Secretary

:

MR. DEO BENG CHOO

IC / PP No

:

6153706

New IC No

:

610319-04-5103

Address

:

NO. 4A, LORONG 2, JALAN SJ 1/9, TAMAN SERI JATI, BATU BERENDAM, 75350 BATU BERENDAM, MELAKA, MALAYSIA.

 

BANKING


Banking relations are maintained principally with :

1)

Name

:

MALAYAN BANKING BHD

 

 

ENCUMBRANCE (S)


No encumbrance was found in our databank at the time of investigation. 

 

 

CIVIL LITIGATION CHECK - SUBJECT COMPANY AS A DEFENDANT


* A check has been conducted in our databank against the Subject whether the Subject has been involved in any litigation. Our databank consists of 99% of the wound up companies in Malaysia.

No legal action was found in our databank.

No winding up petition was found in our databank.

CRIMINAL RECORDS CHECK - SUBJECT COMPANY AS A DEFENDANT


* A check has been conducted in our databank against the Subject whether the Subject has been involved in any litigation. Our databank consists of 99% of the wound up companies in Malaysia.

No criminal record was found in our databank.

CIVIL LITIGATION CHECK - SUBJECT COMPANY AS A PLAINTIFF


* A check has been conducted in our databank against the Subject whether the Subject has been involved in any litigation. Our databank consists of 99% of the wound up companies in Malaysia.

No plaintiff record was found in our databank.

CRIMINAL RECORDS CHECK - SUBJECT COMPANY AS A PLAINTIFF


* A check has been conducted in our databank against the Subject whether the Subject has been involved in any litigation. Our databank consists of 99% of the wound up companies in Malaysia.

No plaintiff record was found in our databank.

DEFAULTER CHECK AGAINST SUBJECT


* We have checked through the Subject in our defaulters' database which comprised of debtors that have been listed by our customers and debtors that have been placed or assigned to us for collection. 

No defaulter record & debt collection case was found in our defaulters' databank. 

 

PAYMENT RECORD

 

 

SOURCES OF RAW MATERIALS:

Local

:

YES

Overseas

:

YES

 

CLIENTELE

 

Local

:

YES

Percentage

:

100%

Domestic Markets

:

MALAYSIA

Overseas

:

NO

Credit Term

:

N/A

Payment Mode

:

CHEQUES

 

OPERATIONS

 

Goods Traded

:

MEDICAL EQUIPMENT

 

Branch

:

NO

 

Other Information:


The Subject is principally engaged in the (as a / as an) trading of medical equipment. 

The Subject mainly sells imaging medical equipments such as x-ray,scanning equipments and others. 


RECENT DEVELOPMENT


We have checked with the Malaysian National News Agency's (BERNAMA) database, but no recent development was noted during the time of inspection.

 

CURRENT INVESTIGATION

 

Latest fresh investigations carried out on the Subject indicated that :

Telephone Number Provided By Client

:

60 62533048

Current Telephone Number

:

06-2533048

Match

:

YES

Address Provided by Client

:

NO. 155, JALAN TU 3 TAMAN TASEK UTAMA 75450 AYER KEROH MELAKA

Current Address

:

NO. 155, JALAN TU 3, TAMAN TASEK UTAMA,, 75450 AIR KEROH, MELAKA, MALAYSIA.

Match

:

YES

Latest Financial Accounts

:

YES

 

Other Investigations


We contacted one of the staff from the Subject and she provided some information.

She refused to disclose the number of employees. It does not use fax facility.


FINANCIAL ANALYSIS

 

Profitability

Turnover

:

Erratic

[

2012 - 2016

]

Profit/(Loss) Before Tax

:

Decreased

[

2012 - 2016

]

Return on Shareholder Funds

:

Unfavourable

[

(115.87%)

]

Return on Net Assets

:

Unfavourable

[

(115.87%)

]

The fluctuating turnover reflects the fierce competition among the existing and new market players.The Subject could be more efficient in controlling its operating costs and had managed to reduce its losses during the year. The Subject's unfavourable returns on shareholders' funds indicate the management's inefficiency in utilising its assets to generate returns.

Liquidity

Current Ratio

:

Acceptable

[

1.01 Times

]

The Subject has an adequate liquidity position with its current liabilities well covered by its current assets. With its net current assets, the Subject should be able to repay its short term obligations.

Solvency

Liability Ratio

:

Unfavourable

[

5.90 Times

]

The Subject has high liabilities ratio and it may face financial difficulties if no additional capital is injected.

Overall Assessment :

The Subject's turnover showed a volatile trend but its losses were lower when compared to the previous corresponding period. This could suggest that the Subject was more efficient in its operating cost control and was more competitive. The Subject was in good liquidity position with its total current liabilities well covered by its total current assets. With its current net assets, the Subject should be able to repay its short term obligations. The Subject's liabilities level was high and its going concern will be in doubt if there is no injection of additional shareholders' funds in times of economic downturn and / or high interest rates.

Overall financial condition of the Subject : POOR

 

 

MALAYSIA ECONOMIC / INDUSTRY OUTLOOK

 

Major Economic Indicators:

2014

2015

2016

2017*

2018**

Population ( Million)

30.0

31.0

31.6

32.1

32.9

Gross Domestic Products ( % )

6.0

4.6

4.2

5.3

5.4

Domestic Demand ( % )

6.4

6.2

4.3

6.3

6.4

Private Expenditure ( % )

7.9

6.9

7.8

7.4

7.3

Consumption ( % )

6.5

6.1

5.1

6.9

6.8

Investment ( % )

12.0

8.1

10.0

9.3

8.9

Public Expenditure ( % )

2.3

4.2

3.3

5.3

5.5

Consumption ( % )

2.1

4.3

2.0

2.7

1.3

Investment ( % )

2.6

(1.0)

1.1

3.4

3.8

Balance of Trade ( MYR Million )

82,480

91,577

88,145

94,593

96,993

Government Finance ( MYR Million )

(37,414)

(37,194)

(38,401)

(39,887)

(39,790)

Government Finance to GDP / Fiscal Deficit ( % )

(3.4)

(3.2)

(3.1)

(3.0)

(2.8)

Inflation ( % Change in Composite CPI)

3.2

4.0

2.1

3.5

3.0

Unemployment Rate

2.9

3.1

3.4

3.4

3.3

Net International Reserves ( MYR Billion )

417

390

391

-

-

Average Risk-Weighted Capital Adequacy Ratio ( % )

4.00

3.50

-

-

-

Average 3 Months of Non-performing Loans ( % )

2.10

2.00

1.90

-

-

Average Base Lending Rate ( % )

6.85

6.79

6.81

6.73

-

Business Loans Disbursed( % )

18.6

2.2

-

-

-

Foreign Investment ( MYR Million )

43,486.6

43,435.0

-

-

-

Consumer Loans ( % )

-

-

-

-

-

Registration of New Companies ( No. )

49,203

45,658

43,255

-

-

Registration of New Companies ( % )

6.1

(7.2)

(5.3)

-

-

Liquidation of Companies ( No. )

11,099

7,066

-

-

-

Liquidation of Companies ( % )

(19.5)

(36.3)

-

-

-

Registration of New Business ( No. )

332,723

364,230

376,720

-

-

Registration of New Business ( % )

1.0

9.0

3.0

-

-

Business Dissolved ( No. )

21,436

-

-

-

-

Business Dissolved ( % )

18.0

-

-

-

-

Sales of New Passenger Cars (' 000 Unit )

588.3

591.3

514.6

527.8

-

Cellular Phone Subscribers ( Million )

44.0

44.2

44.0

-

-

Tourist Arrival ( Million Persons )

27.4

25.7

30.2

30.1

-

Hotel Occupancy Rate ( % )

63.6

58.8

61.2

-

-

Credit Cards Spending ( % )

5.8

6.8

6.3

-

-

Bad Cheque Offenders (No.)

-

-

-

-

-

Individual Bankruptcy ( No.)

22,351

18,457

-

-

-

Individual Bankruptcy ( % )

1.7

(17.4)

-

-

-



INDUSTRIES ( % of Growth ):

2014

2015

2016

2017*

2018**

Agriculture

2.0

1.3

(5.1)

5.6

2.4

Palm Oil

6.7

7.0

(12.7)

11.8

-

Rubber

(10.4)

(11.0)

(6.3)

10.8

-

Forestry & Logging

(4.2)

(7.2)

(3.0)

(15.0)

-

Fishing

2.7

2.1

2.2

0.2

-

Other Agriculture

6.2

6.0

5.1

2.4

-

Industry Non-Performing Loans ( MYR Million )

303.8

343.7

420.3

-

-

% of Industry Non-Performing Loans

1.4

1.5

1.8

-

-

Mining

3.3

5.3

2.2

0.5

0.9

Oil & Gas

3.0

3.5

4.5

-

-

Other Mining

46.6

47.1

42.6

-

-

Industry Non-performing Loans ( MYR Million )

63.5

180.1

190.0

-

-

% of Industry Non-performing Loans

0.3

0.8

0.8

-

-

Manufacturing #

6.1

4.9

4.4

5.5

5.3

Exported-oriented Industries

7.1

6.5

4.3

6.5

-

Electrical & Electronics

11.8

9.2

6.8

9.3

-

Rubber Products

(1.3)

5.1

5.0

6.9

-

Wood Products

7.8

7.0

7.8

7.3

-

Textiles & Apparel

10.8

7.5

7.5

7.4

-

Domestic-oriented Industries

7.7

4.7

3.4

6.2

-

Food, Beverages & Tobacco

6.1

8.9

7.5

11.0

-

Chemical & Chemical Products

1.4

3.5

4.5

3.5

-

Plastic Products

2.7

3.9

5.1

-

-

Iron & Steel

2.8

1.6

2.2

-

-

Fabricated Metal Products

2.8

4.6

5.6

4.6

-

Non-metallic Mineral

6.9

6.8

6.3

5.4

-

Transport Equipment

14.4

5.2

(3.1)

4.7

-

Paper & Paper Products

4.7

3.2

5.4

5.8

-

Crude Oil Refineries

13.0

14.3

13.7

-

-

Industry Non-Performing Loans ( MYR Million )

5,730.8

4,243.7

4,214.1

-

-

% of Industry Non-Performing Loans

25.6

19.0

18.5

-

-

Construction

11.7

8.2

7.4

7.6

7.5

Industry Non-Performing Loans ( MYR Million )

1,666.4

1,638.0

1,793.9

-

-

% of Industry Non-Performing Loans

7.5

7.3

7.9

-

-

Services

6.6

5.1

5.6

5.9

5.8

Electric, Gas & Water

3.8

3.6

5.4

2.5

2.6

Transport, Storage & Communication

7.70

7.55

6.85

7.35

7.30

Wholesale, Retail, Hotel & Restaurant

7.70

6.65

6.65

7.05

6.65

Finance, Insurance & Real Estate

5.15

2.90

4.70

5.70

5.90

Government Services

6.3

4.0

4.9

4.4

4.5

Other Services

4.8

4.7

4.8

5.3

5.3

Industry Non-Performing Loans ( MYR Million )

5,373.5

6,806.6

7,190.6

-

-

% of Industry Non-Performing Loans

24.1

30.5

31.5

-

-

* Estimate / Preliminary

** Forecast

# Based On Manufacturing Production Index 



INDUSTRY ANALYSIS

 

MSIC CODE

46421 : Wholesale of pharmaceutical and medical goods

INDUSTRY :

TRADING

Malaysia's retail sales will likely grow 3.7% in 2017, slower than previously estimated 3.9%, as consumer sentiment remains weak amid rising cost of living in Southeast Asia's third largest economy.

The cut in forecast was the second of such revision by Retail Group Malaysia, a retail consulting firm, from an initial target of 5% retail sales expansion pace in 2017. The estimate follows a survey of members of Malaysia Retailers Association on their second quarter performance and outlook for the year. Retail sales grew 1.7% in 2016.

According to Retail Group Malaysia (RGM), Malaysian retailers have seen the sales expanded 4.9 % from April to June 2017, reversing a dismal performance in first three months 2017. For the first six months 2016, the retail sale growth rate was 2.5 %. However, the businesses in the next three months are not optimistic, estimating an average growth rate of 2.9 %. The department stores cum supermarket operators are expecting to return to red with a contraction of 2.5 %. Similarly, the department store operators expect their businesses to dip with a negative 1.5 %.

The rise of purchasing power will continue to fall behind the increase in prices of retail goods. More retail goods are expected to raise prices because of higher fuel prices in recent months.

The wholesale trade sub-sector index increased 5.9 % to 165.9 points year-on-year (y-o-y) driven mainly by other specialised wholesale (7.5 %), wholesale of agricultural raw materials and livestock (7.3 %) and wholesale of machinery, equipment and supplies (6.2 %).

Over 60% of Gross Domestic Product (GDP) is contributed by domestic consumption. Therefore the wholesale and retail sector plays a crucial role in driving Malaysia's growth over the next decade despite the ongoing global economic slowdown. By 2020, Malaysia's wholesale and retail sector is expected to boost the country's total Gross National Income (GNI) by RM156 billion, creating 454,190 new jobs.

OVERALL INDUSTRY OUTLOOK : Marginal Growth



CREDIT RISK EVALUATION & RECOMMENDATION

 


Incorporated in 2007, the Subject is a Private Limited company, focusing on trading of medical equipment. Having been in the industry for over a decade, the Subject has achieved a certain market share and has built up a satisfactory reputation in the market. It should have received supports from its regular customers. The Subject is considered as a medium size company with issued and paid up capital standing at MYR 500,000. The Subject does not have strong shareholders' backing. Without a strong shareholders' backing, the opportunity of the Subject to expand its business is limited. 

Investigation revealed that the Subject concentrates only on the local market. This narrow market segment has placed the Subject at high business risk and limits its business expansion opportunities. Any adverse changes to the local economy might have a negative impact on the Subject's business performance. Overall, we regard that the Subject's management capability is average. This indicates that the Subject has greater potential to improve its business performance and raising income for the Subject. 

Despite the higher turnover, the Subject suffered pre-tax losses which reflected a highly competitive business environment. The Subject has generated an unfavourable return on shareholders' funds indicating that the management was inefficient in utilising its funds to generate return. The Subject managed to maintain an adequate liquidity level, indicating that the Subject has the ability to meet its financial obligations. The Subject has high liabilities ratio and it may face financial difficulties if no additional capital is injected. 

The Subject's supplier are from both the local and overseas countries. This will eliminates the risk of dependency on deliveries from a number of key suppliers and insufficient quantities of its raw materials. Overall the Subject has a good control over its resources. 

The industry has reached its maturity stage and only enjoying a marginal growth. The steady growth of the country's economy will further enhance the industry activities. Thus, the Subject's future performance is very much depend on its marketing strategies in order to retain its position in the market. 

Based on the above unfavourable condition, we regard granting credit to the Subject to be quite risky. Hence, credit is not recommended.



PROFIT AND LOSS ACCOUNT

 

THE FINANCIAL STATEMENTS WERE PREPARED IN ACCORDANCE WITH MALAYSIAN FINANCIAL REPORTING STANDARDS(FRS)

EVEREST MEDICAL RESOURCES (M) SDN. BHD.

 

Financial Year End

2016-06-30

2015-06-30

2014-06-30

2013-06-30

2012-06-30

Months

12

12

12

12

12

Consolidated Account

Company

Company

Company

Company

Company

Audited Account

YES

YES

YES

YES

YES

Unqualified Auditor's Report (Clean Opinion)

NO

YES

YES

YES

YES

Financial Type

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

Currency

MYR

MYR

MYR

MYR

MYR

TURNOVER

187,641

66,098

878,193

1,815,894

11,331,943

----------------

----------------

----------------

----------------

----------------

Total Turnover

187,641

66,098

878,193

1,815,894

11,331,943

----------------

----------------

----------------

----------------

----------------

PROFIT/(LOSS) FROM OPERATIONS

(101,566)

(532,945)

(25,165)

(89,113)

105,967

----------------

----------------

----------------

----------------

----------------

PROFIT/(LOSS) BEFORE TAXATION

(101,566)

(532,945)

(25,165)

(89,113)

105,967

Taxation

-

-

-

(790)

(32,915)

----------------

----------------

----------------

----------------

----------------

PROFIT/(LOSS) AFTER TAXATION

(101,566)

(532,945)

(25,165)

(89,903)

73,052

----------------

----------------

----------------

----------------

----------------

RETAINED PROFIT/(LOSS) BROUGHT FORWARD

As previously reported

(310,781)

222,164

247,779

337,682

264,630

----------------

----------------

----------------

----------------

----------------

As restated

(310,781)

222,164

247,779

337,682

264,630

----------------

----------------

----------------

----------------

----------------

PROFIT AVAILABLE FOR APPROPRIATIONS

(412,347)

(310,781)

222,614

247,779

337,682

----------------

----------------

----------------

----------------

----------------

RETAINED PROFIT/(LOSS) CARRIED FORWARD

(412,347)

(310,781)

222,614

247,779

337,682

=============

=============

=============

=============

=============

 

 

 

 

 

 

 

BALANCE SHEET

 

EVEREST MEDICAL RESOURCES (M) SDN. BHD.

 

ASSETS EMPLOYED:

FIXED ASSETS

80,320

136,088

223,958

338,745

430,541

----------------

----------------

----------------

----------------

----------------

TOTAL LONG TERM ASSETS

80,320

136,088

223,958

338,745

430,541

CURRENT ASSETS

TOTAL CURRENT ASSETS

524,602

605,496

1,042,553

950,958

1,672,486

----------------

----------------

----------------

----------------

----------------

TOTAL ASSET

604,922

741,584

1,266,511

1,289,703

2,103,027

=============

=============

=============

=============

=============

CURRENT LIABILITIES

TOTAL CURRENT LIABILITIES

517,269

529,351

496,155

622,302

1,319,466

----------------

----------------

----------------

----------------

----------------

NET CURRENT ASSETS/(LIABILITIES)

7,333

76,145

546,398

328,656

353,020

----------------

----------------

----------------

----------------

----------------

LONG TERM LIABILITIES

TOTAL LONG TERM LIABILITIES

-

23,014

48,192

69,622

95,879

----------------

----------------

----------------

----------------

----------------

TOTAL NET ASSETS

87,653

189,219

722,164

597,779

687,682

=============

=============

=============

=============

=============

SHARE CAPITAL

Ordinary share capital

500,000

500,000

500,000

350,000

350,000

----------------

----------------

----------------

----------------

----------------

TOTAL SHARE CAPITAL

500,000

500,000

500,000

350,000

350,000

RESERVES

Share premium

-

(310,781)

222,164

247,779

-

Retained profit/(loss) carried forward

(412,347)

-

-

-

337,682

----------------

----------------

----------------

----------------

----------------

TOTAL RESERVES

(412,347)

(310,781)

222,164

247,779

337,682

----------------

----------------

----------------

----------------

----------------

SHAREHOLDERS' FUNDS/EQUITY

87,653

189,219

722,164

597,779

687,682

=============

=============

=============

=============

=============

 

 

 

 

 

 

 

FINANCIAL RATIO

 

EVEREST MEDICAL RESOURCES (M) SDN. BHD.

 

TYPES OF FUNDS

Net Liquid Assets

7,333

76,145

546,398

328,656

353,020

Net Current Assets/(Liabilities)

7,333

76,145

546,398

328,656

353,020

Net Tangible Assets

87,653

189,219

722,164

597,779

687,682

Net Monetary Assets

7,333

53,131

498,206

259,034

257,141

BALANCE SHEET ITEMS

Total Liabilities

517,269

552,365

544,347

691,924

1,415,345

Total Assets

604,922

741,584

1,266,511

1,289,703

2,103,027

Net Assets

87,653

189,219

722,164

597,779

687,682

Net Assets Backing

87,653

189,219

722,164

597,779

687,682

Shareholders' Funds

87,653

189,219

722,164

597,779

687,682

Total Share Capital

500,000

500,000

500,000

350,000

350,000

Total Reserves

(412,347)

(310,781)

222,164

247,779

337,682

GROWTH RATIOS (Year on Year) (%)

Revenue

183.88

(92.47)

(51.64)

(83.98)

6.42

Proft/(Loss) Before Tax

80.94

(2,017.80)

71.76

(184.10)

19.39

Proft/(Loss) After Tax

80.94

(2,017.80)

72.01

(223.07)

14.41

Total Assets

(18.43)

(41.45)

(1.80)

(38.67)

(16.86)

Total Liabilities

(6.35)

1.47

(21.33)

(51.11)

(26.09)

LIQUIDITY (Times)

Current Ratio

1.01

1.14

2.10

1.53

1.27

SOLVENCY RATIOS (Times)

Liabilities Ratio

5.90

2.92

0.75

1.16

2.06

Assets Backing Ratio

0.18

0.38

1.44

1.71

1.96

PERFORMANCE RATIO (%)

Operating Profit Margin

(54.13)

(806.30)

(2.87)

(4.91)

0.94

Net Profit Margin

(54.13)

(806.30)

(2.87)

(4.95)

0.64

Return On Net Assets

(115.87)

(281.66)

(3.48)

(14.91)

15.41

Return On Capital Employed

(115.87)

(251.11)

(3.27)

(13.35)

13.52

Return On Shareholders' Funds/Equity

(115.87)

(281.66)

(3.48)

(15.04)

10.62




 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

INR 65.13

UK Pound

1

INR 91.95

Euro

1

INR 80.34

MYR

1

INR 16.60

 

Note : Above are approximate rates obtained from sources believed to be correct

 

 

INFORMATION DETAILS

 

Analysis Done by :

PRA

 

 

Report Prepared by :

TPT

 


 

RATING EXPLANATIONS

 

Credit Rating

 

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.